Literature DB >> 33507149

Induction of the IL-1RII decoy receptor by NFAT/FOXP3 blocks IL-1β-dependent response of Th17 cells.

Dong Hyun Kim1, Hee Young Kim1,2,3, Sunjung Cho2, Su-Jin Yoo4, Won-Ju Kim5, Hye Ran Yeon6, Kyungho Choi6, Je-Min Choi5, Seong Wook Kang4, Won-Woo Lee1,2,3,7.   

Abstract

Derived from a common precursor cell, the balance between Th17 and Treg cells must be maintained within immune system to prevent autoimmune diseases. IL-1β-mediated IL-1 receptor (IL-1R) signaling is essential for Th17-cell biology. Fine-tuning of IL-1R signaling is controlled by two receptors, IL-1RI and IL-RII, IL-1R accessory protein, and IL-1R antagonist. We demonstrate that the decoy receptor, IL-1RII, is important for regulating IL-17 responses in TCR-stimulated CD4+ T cells expressing functional IL-1RI via limiting IL-1β responsiveness. IL-1RII expression is regulated by NFAT via its interaction with Foxp3. The NFAT/FOXP3 complex binds to the IL-1RII promoter and is critical for its transcription. Additionally, IL-1RII expression is dysregulated in CD4+ T cells from patients with rheumatoid arthritis. Thus, differential expression of IL-1Rs on activated CD4+ T cells defines unique immunological features and a novel molecular mechanism underlies IL-1RII expression. These findings shed light on the modulatory effects of IL-1RII on Th17 responses.
© 2021, Kim et al.

Entities:  

Keywords:  Foxp3; IL-1 receptor; IL-1β; NFAT; Th17; human; immunology; inflammation; rheumatoid arthritis (RA)

Mesh:

Substances:

Year:  2021        PMID: 33507149      PMCID: PMC7872515          DOI: 10.7554/eLife.61841

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  69 in total

1.  Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis.

Authors:  Noriko Komatsu; Kazuo Okamoto; Shinichiro Sawa; Tomoki Nakashima; Masatsugu Oh-hora; Tatsuhiko Kodama; Sakae Tanaka; Jeffrey A Bluestone; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2013-12-22       Impact factor: 53.440

2.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.

Authors:  F Colotta; F Re; M Muzio; R Bertini; N Polentarutti; M Sironi; J G Giri; S K Dower; J E Sims; A Mantovani
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

3.  Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockade.

Authors:  Scott M Krummey; Tamara L Floyd; Danya Liu; Maylene E Wagener; Mingqing Song; Mandy L Ford
Journal:  J Immunol       Date:  2014-02-03       Impact factor: 5.422

4.  Alleviation of collagen-induced arthritis by the benzoxathiole derivative BOT-4-one in mice: Implication of the Th1- and Th17-cell-mediated immune responses.

Authors:  Byung-Hak Kim; Bo Ruem Yoon; Eun Kyoung Kim; Kum Hee Noh; Sun-Ho Kwon; Eun Hee Yi; Hyun Gyu Lee; Jung Sook Choi; Seong Wook Kang; In-Chul Park; Won-Woo Lee; Sang-Kyu Ye
Journal:  Biochem Pharmacol       Date:  2016-03-19       Impact factor: 5.858

5.  Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.

Authors:  Nataša Obermajer; Felix C Popp; Yorick Soeder; Jan Haarer; Edward K Geissler; Hans J Schlitt; Marc H Dahlke
Journal:  J Immunol       Date:  2014-10-10       Impact factor: 5.422

6.  IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance.

Authors:  Rajatava Basu; Sarah K Whitley; Suniti Bhaumik; Carlene L Zindl; Trenton R Schoeb; Etty N Benveniste; Warren S Pear; Robin D Hatton; Casey T Weaver
Journal:  Nat Immunol       Date:  2015-02-02       Impact factor: 25.606

7.  Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells.

Authors:  Stephanie Downs-Canner; Sara Berkey; Greg M Delgoffe; Robert P Edwards; Tyler Curiel; Kunle Odunsi; David L Bartlett; Nataša Obermajer
Journal:  Nat Commun       Date:  2017-03-14       Impact factor: 14.919

8.  NFAT-Specific Inhibition by dNP2-VIVITAmeliorates Autoimmune Encephalomyelitisby Regulation of Th1 and Th17.

Authors:  Hong-Gyun Lee; Li-Kyung Kim; Je-Min Choi
Journal:  Mol Ther Methods Clin Dev       Date:  2019-10-23       Impact factor: 6.698

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Induction and molecular signature of pathogenic TH17 cells.

Authors:  Youjin Lee; Amit Awasthi; Nir Yosef; Francisco J Quintana; Sheng Xiao; Anneli Peters; Chuan Wu; Markus Kleinewietfeld; Sharon Kunder; David A Hafler; Raymond A Sobel; Aviv Regev; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-09-09       Impact factor: 25.606

View more
  1 in total

Review 1.  Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.

Authors:  Domenico Supino; Luna Minute; Andrea Mariancini; Federica Riva; Elena Magrini; Cecilia Garlanda
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.